Baĭsogolov G D, Shakhtarina S V
Med Radiol (Mosk). 1984 Apr;29(4):46-50.
The authors present the results of the combined treatment (radiotherapy combined with 6 cycles of polychemotherapy using either the COPP or CVPP scheme) of 120 patients according to 4 programs differing in the volume of irradiation and intervals, between the cycles of polychemotherapy. The results of the study were compared to those of radiotherapy (irradiation of unilateral diaphragmatic and splenic lymph nodes) of 277 patients with Hodgkin's disease, Stages I--II. The combined treatment was shown to yield in better rates of a recurrence-free course of the disease and in slightly increased 3-year survival rates. It was shown that with identical drug therapy (6 cycles of polychemotherapy) the results of treatment in the groups of patients with different volumes of irradiation (irradiation of the clinically detectable foci of lesion only or of all the lymph nodes over the diaphragm and spleen) are rather similar. The results obtained indicate the advantages of the combined method of treatment of patients with Hodgkin's disease, Stages I--II. A reduced volume of irradiation seems possible in some cases.
作者介绍了120例患者根据4种方案进行联合治疗(放疗联合使用COPP或CVPP方案的6周期多药化疗)的结果,这4种方案在照射范围和多药化疗周期之间的间隔方面存在差异。将该研究结果与277例I-II期霍奇金病患者接受放疗(单侧膈肌和脾脏淋巴结照射)的结果进行了比较。结果显示,联合治疗在无病复发病程率方面表现更好,3年生存率略有提高。结果表明,在相同的药物治疗(6周期多药化疗)下,不同照射范围(仅照射临床可检测到的病变部位或膈肌和脾脏上方的所有淋巴结)的患者组治疗结果相当相似。所获得的结果表明了I-II期霍奇金病患者联合治疗方法的优势。在某些情况下,似乎可以减少照射范围。